Sanofi said the review of what's called tolebrutinib, to treat non-relapsing secondary progressive multiple sclerosis, will extend beyond Dec. 28, and that it expects further guidance by the U.S. Food ...

Global stock markets were mixed to start the week, with falls across Asia even as European bourses opened up and U.S. stock futures pointed to a modestly higher open. Weak Chinese economic data and ...

The projected surplus has narrowed due to lower OPEC+ production, but a large supply overhang continues to cloud the outlook, the International Energy Agency said. The sale accounts for about 7.1% of ...

Tariffs will curb the Philippines' economic momentum this year, the International Monetary Fund said as it cut its growth forecast for the Southeast Asian country.

Shares of CMOC Group rose after the Chinese mining giant said it is purchasing several Brazilian gold mines from Canada's Equinox Gold in a deal worth over US$1 billion. Under the agreement, CMOC ...

Dow Jones Top Markets Headlines at 3 AM ET: China's Economy Is Deteriorating on Several Fronts | BOJ ... The broad-based weakening spans consumer spending, investment and real estate. Japanese ...

Dow Jones Top Company Headlines at 3 AM ET: Sanofi Multiple Sclerosis Drug Hit by Double Setback | China ... A U.S. regulatory decision on tolebrutinib will again be delayed while a late-stage trial ...

The holding company of Italy's Agnelli family rejected an offer from cryptocurrency issuer Tether for its majority stake in Juventus Football Club, in the latest attempt by a financial group to push ...

The government doesn't like it because it recognizes inflation is one big reason why the economy is weak, why consumer spending is so tepid. And they also don't like a weak yen because it amplifies ...

Danske Bank completed a period of corporate probation with the U.S. Justice Department, marking the end of a yearslong process that was started in the aftermath of a series of money-laundering ...

Alphabet's Google has signed a solar power-purchase agreement in Malaysia with Japan's Shizen Energy, as technology giants increasingly turn to renewables to power energy-intensive ...

Sanofi said a U.S. regulatory decision on its tolebrutinib experimental treatment for a type of multiple sclerosis would be delayed again, and that a late-stage trial for a different form of the ...